S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                   8255
 
                             I N  S E N A T E
 
                              April 29, 2020
                                ___________
 
 Introduced  by Sens. RIVERA, HOYLMAN, KAMINSKY, KRUEGER, SALAZAR -- read
   twice and ordered printed, and when printed to  be  committed  to  the
   Committee on Insurance
 
 AN  ACT  to amend the insurance law, in relation to capping cost sharing
   for insulin
 
   THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
 BLY, DO ENACT AS FOLLOWS:

   Section  1.  Subparagraph  (B)  of paragraph 15-a of subsection (i) of
 section 3216 of the insurance law, as amended by section 1 of  part  DDD
 of chapter 56 of the laws of 2020, is amended to read as follows:
   (B) Such coverage may be subject to annual deductibles and coinsurance
 as may be deemed appropriate by the superintendent and as are consistent
 with  those  established  for  other  benefits  within  a  given policy;
 provided however, the total amount that a covered person is required  to
 pay out of pocket for covered prescription insulin drugs shall be capped
 at  an  amount not to exceed [one hundred] THIRTY dollars per thirty-day
 supply, regardless of the amount or type of insulin needed to fill  such
 covered  person's  prescription  and regardless of the insured's deduct-
 ible, copayment, coinsurance or any other cost sharing requirement.
   § 2. Subparagraph (B) of paragraph 7 of subsection (k) of section 3221
 of the insurance law, as amended by section 2 of part DDD of chapter  56
 of the laws of 2020, is amended to read as follows:
   (B) Such coverage may be subject to annual deductibles and coinsurance
 as may be deemed appropriate by the superintendent and as are consistent
 with  those  established  for  other  benefits  within  a  given policy;
 provided however, the total amount that a covered person is required  to
 pay out of pocket for covered prescription insulin drugs shall be capped
 at  an  amount not to exceed [one hundred] THIRTY dollars per thirty-day
 supply, regardless of the amount or type of insulin needed to fill  such
 covered  person's  prescription  and regardless of the insured's deduct-
 ible, copayment, coinsurance or any other cost sharing requirement.
   § 3. Paragraph 2 of subsection (u) of section 4303  of  the  insurance
 law,  as  amended  by section 3 of part DDD of chapter 56 of the laws of
 2020, is amended to read as follows:
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
              

                       [ ] is old law to be omitted.
                                                            LBD16178-01-0

 S. 8255                             2
 
   (2) Such coverage may be subject to annual deductibles and coinsurance
 as may be deemed appropriate by the superintendent and as are consistent
 with those  established  for  other  benefits  within  a  given  policy;
 provided  however, the total amount that a covered person is required to
 pay out of pocket for covered prescription insulin drugs shall be capped
 at  an  amount not to exceed [one hundred] THIRTY dollars per thirty-day
 supply, regardless of the amount or type of insulin needed to fill  such
 covered  person's  prescription  and regardless of the insured's deduct-
 ible, copayment, coinsurance or any other cost sharing requirement.
   § 4. This act shall take effect immediately and  shall  apply  to  any
 policy or contract issued or renewed on or after January 1, 2021.